transdermal ozone linked to lower liver enzyme and bilirubin levels during chemotherapy
Ozone therapy normalized liver function markers in breast cancer patients undergoing chemotherapy, with significant decreases in ALT (from 29.0 to 20.0 U/L), AST (from 32.0 to 19.0 U/L), and total bilirubin (from 16.0 to 11.0 µmol/L), compared to increases in the control group.
What this means for you
Liver enzymes like ALT and AST are markers your doctor watches to see how hard your liver is working. When they trend down, it generally signals less stress on the liver — the organ responsible for filtering toxins, metabolizing nutrients, and keeping your energy steady. Supporting liver function during periods of high physiological demand is something many wellness-focused people actively prioritize.
The published research
Ozonetherapy in a Complex Treatment of Breast Cancer
· 1980
This page describes a documented finding about the underlying wellness technology. It is not a marketing claim about any specific device. For information about HOCATT specifically, visit hocatt.com.